Mutations in a TGF- b Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections

BACKGROUND Aneurysms affecting the aorta are a common condition associated with high mortality as a result of aortic dissection or rupture. Investigations of the pathogenic mechanisms involved in syndromic types of thoracic aortic aneurysms, such as Marfan and Loeys-Dietz syndromes, have revealed an important contribution of disturbed transforming growth factor (TGF)- b signaling. OBJECTIVES This study sought to discover a novel gene causing syndromic aortic aneurysms in order to unravel the underlying pathogenesis. METHODS We combined genome-wide linkage analysis, exome sequencing, and candidate gene Sanger sequencing in a total of 470 index cases with thoracic aortic aneurysms. Extensive cardiological examination, including physical examination, electrocardiography, and transthoracic echocardiography was performed. In adults, imaging of the entire aorta using computed tomography or magnetic resonance imaging was done. RESULTS Here, we report on 43 patients from 11 families with syndromic presentations of aortic aneurysms caused by TGFB3 mutations. We demonstrate that TGFB3 mutations are associated with signi fi cant cardiovascular involvement, including thoracic/abdominal aortic aneurysm and dissection, and mitral valve disease. Other systemic features overlap clinically with Loeys-Dietz, Shprintzen-Goldberg, and Marfan syndromes, including cleft palate, bi fi d uvula, skeletal overgrowth, cervical spine instability and clubfoot deformity. In line with previous observations in aortic wall

[1]  R. Devereux,et al.  Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. , 2014, The American journal of cardiology.

[2]  D. Constam.  Regulation of TGFβ and related signals by precursor processing. , 2014, Seminars in cell & developmental biology.

[3]  H. Rienhoff.  Response to “De novo mutation of the TGFB3 latency‐associated peptide domain in a patient with overgrowth and Loeys–Dietz syndrome features” , 2014, American journal of medical genetics. Part A.

[4]  K. Oexle,et al.  De novo mutation of the latency‐associated peptide domain of TGFB3 in a patient with overgrowth and Loeys–Dietz syndrome features , 2014, American journal of medical genetics. Part A.

[5]  Gert Vriend,et al.  YASARA View—molecular graphics for all devices—from smartphones to workstations , 2014, Bioinform..

[6]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[7]  Sarah J. Parker,et al.  Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. , 2014, The Journal of clinical investigation.

[8]  S. Luo,et al.  A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with marfan and loeys–dietz syndrome , 2013, American journal of medical genetics. Part A.

[9]  Matthias F Kriegel,et al.  Distribution, determinants, and normal reference values of thoracic and abdominal aortic diameters by computed tomography (from the Framingham Heart Study). , 2013, The American journal of cardiology.

[10]  Seneca L. Bessling,et al.  Mutations in the TGF-β Repressor SKI Cause Shprintzen-Goldberg Syndrome with Aortic Aneurysm , 2012, Nature Genetics.

[11]  J. Timmermans,et al.  Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. , 2012, Journal of the American College of Cardiology.

[12]  G. Pals,et al.  Phenotypic spectrum of the SMAD3-related aneurysms–osteoarthritis syndrome , 2011, Journal of Medical Genetics.

[13]  T. Walz,et al.  Latent TGF-β structure and activation , 2011, Nature.

[14]  H. Dietz,et al.  Lessons on the pathogenesis of aneurysm from heritable conditions , 2011, Nature.

[15]  G. Vriend,et al.  Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.

[16]  Morris A. Swertz,et al.  The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button , 2010, BMC Bioinformatics.

[17]  B. Oostra,et al.  First locus for primary pulmonary vein stenosis maps to chromosome 2q. , 2009, European heart journal.

[18]  S. Pawlowski,et al.  Generation of mice with a conditional allele for the transforming growth factor beta3 gene , 2009, Genesis.

[19]  Raymond B. Runyan,et al.  Ligand‐specific function of transforming growth factor beta in epithelial‐mesenchymal transition in heart development , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[20]  Zhiwei Yang,et al.  Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice , 2007, The Journal of cell biology.

[21]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[22]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[23]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[24]  Tom H. Lindner,et al.  easyLINKAGE-Plus--automated linkage analyses using large-scale SNP data , 2005, Bioinform..

[25]  Peter J. Nürnberg,et al.  HaploPainter: a tool for drawing pedigrees with complex haplotypes , 2005, Bioinform..

[26]  Yusuke Nakamura,et al.  Heterozygous TGFBR2 mutations in Marfan syndrome , 2004, Nature Genetics.

[27]  G. Dorn,et al.  Transforming growth factor beta in cardiovascular development and function. , 2003, Cytokine & growth factor reviews.

[28]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[29]  W. Baschong,et al.  Control of Autofluorescence of Archival Formaldehyde-fixed, Paraffin-embedded Tissue in Confocal Laser Scanning Microscopy (CLSM) , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[31]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[32]  D. Rifkin,et al.  Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1 , 1998 .

[33]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[34]  V. Kaartinen,et al.  Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction , 1995, Nature Genetics.

[35]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[36]  S. Knudsen,et al.  Prediction of human mRNA donor and acceptor sites from the DNA sequence. , 1991, Journal of molecular biology.

[37]  J. Worthington,et al.  TGFβ: a sleeping giant awoken by integrins. , 2011, Trends in biochemical sciences.

[38]  D. Rifkin,et al.  The integrin alphaVbeta6 binds and activates latent TGFbeta3. , 2002, FEBS letters.

[39]  R. Shprintzen,et al.  A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias. , 1982, Journal of craniofacial genetics and developmental biology.